- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting MET for glioma therapy
Authors
Keywords
-
Journal
Neurosurgical Focus
Volume 37, Issue 6, Pages E10
Publisher
Journal of Neurosurgery Publishing Group (JNSPG)
Online
2014-12-01
DOI
10.3171/2014.9.focus14520
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Vivo c-Met Pathway Inhibition Depletes Human Glioma Xenografts of Tumor-Propagating Stem-Like Cells
- (2014) Prakash Rath et al. Translational Oncology
- Hepatocyte Growth Factor Sensitizes Brain Tumors to c-MET Kinase Inhibition
- (2013) Y. Zhang et al. CLINICAL CANCER RESEARCH
- Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance
- (2013) A. Jahangiri et al. CLINICAL CANCER RESEARCH
- An Orally Bioavailable c-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth
- (2012) Fadila Guessous et al. Anti-Cancer Agents in Medicinal Chemistry
- MET Signaling Regulates Glioblastoma Stem Cells
- (2012) K. M. Joo et al. CANCER RESEARCH
- Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells
- (2012) Kang Ho Kim et al. NEURO-ONCOLOGY
- Hyperactivation of constitutively dimerized oncogenic EGF receptors by autocrine loops
- (2012) J A G C Laisney et al. ONCOGENE
- Glioblastoma survival in the United States before and during the temozolomide era
- (2011) Derek R. Johnson et al. JOURNAL OF NEURO-ONCOLOGY
- A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma
- (2011) P. Y. Wen et al. NEURO-ONCOLOGY
- Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma
- (2011) Q. Xie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype
- (2011) Y. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- c-Met antisense oligodeoxynucleotides increase sensitivity of human glioma cells to paclitaxel
- (2010) Chu ONCOLOGY REPORTS
- Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapy
- (2009) Roger Abounader Expert Review of Anticancer Therapy
- Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy
- (2009) Y. Li et al. MOLECULAR CANCER THERAPEUTICS
- Activation of Notch-Mediated Protective Signaling in the Myocardium
- (2008) Natalie A. Gude et al. CIRCULATION RESEARCH
- Transcription-Dependent Epidermal Growth Factor Receptor Activation by Hepatocyte Growth Factor
- (2008) T. E. Reznik et al. MOLECULAR CANCER RESEARCH
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Drug development of MET inhibitors: targeting oncogene addiction and expedience
- (2008) Paolo M. Comoglio et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More